The Business Journals

Richmond pharma company lands federal contract for nerve-agent antidote

Richmond pharmaceutical company Kaléo Inc. has been tapped by federal agencies to develop a countermeasure to nerve-agent poisoning. A contract from the Biomedical Advanced Research and Development ...
Seeking Alpha

Odyssey Health, Inc. To Develop Intranasal Field- Deliverable Nerve Agent Antidote

Las Vegas Nevada, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (ODSY) (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical ...
Reuters

Emergent Biosolutions awarded U.S. Department of State contract valued at up to $25 mln to supply nerve agent antidote auto-injector

* Emergent Biosolutions Inc - ‍company anticipates making initial deliveries on contract before year-end Source text for Eikon: Further company coverage: Sign up here. Thyssenkrupp continues to be in ...
Firehouse

Meridian Medical Technologies, Inc.

Meridian Medical Technologies, Inc. has been manufacturing auto-injectors for emergency drug delivery for more than 50 years and has provided more than 185 million auto-injectors to the world market.
The Business Journals

Richmond pharma firm Kaléo appoints new chief development officer

Richmond pharmaceutical company Kaléo Inc. has tapped Theresa Matkovits to be its new chief development officer. Matkovits, who was most recently chief development officer at Bedminster, New Jersey’s ...